AB Science announces that Health Canada has resumed its revi

PRESS RELEASE AB SCIENCE ANNOUNCES THAT HEALTH CANADA HAS RESUMED ITS REVIEW OF THE NEW DRUG SUBMISSION FOR MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS, FOLLOWING ISSUANCE OF A SCREENING ACCEPTANCE... | May 9, 2023

Related Keywords

France , Canada , Paris , France General , United States , Boston , Massachusetts , Canadians , American , Alain Moussy , Health Canada , American Academy Of Neurology , New Drug Submission , American Academy , Euronext Paris , Ab Science Stock Exchange , News , Information , Press Release , Dress , Release , Tb , Science , Nnounces , Hat , Health , Gas , Esumed , Its , Review , F , The , Few , Drug , Submission , Or , Asitinib , N , Amyotrophic , Bilateral , Following , Issuance , Creening Ab Fr0010557264 ,